Irinotecan Hydrochloride Injection

Irinotecan comes as a liquid to be given over 90 minutes intravenously (into a vein) by a doctor or nurse. It is usually given not more often than once a week, according to a schedule that alternates one or more weeks when you receive irinotecan with one or more weeks when you do not receive the medication. Your doctor will choose the schedule that will work best for you. Irinotecan is also sometimes used along with other medications to treat small cell lung cancer.

Quick Answer

The anti cancer drugs list includes medicines such as Paclitaxel, Docetaxel, Doxorubicin, Cisplatin, Carboplatin, and Gemcitabine — all of which are manufactured by Medyra Pharma under its oncology division, Medyra Onco. These drugs are essential in cancer treatment, helping to destroy cancer cells, stop tumor growth, and improve patient recovery outcomes.

Introduction

Cancer treatment has evolved tremendously, and today a robust anti cancer drugs list serves as the backbone of modern oncology care. These medicines are essential for stopping tumour growth, preventing metastasis and improving patient outcomes. At Medyra Pharma, our mission as a trusted anti cancer drugs manufacturer is to provide high-quality, safe and affordable oncology medicines that reach patients across the globe.

Our list covers everything from classic chemotherapy agents to cutting-edge targeted therapies—designed to match diverse patient needs and tumour types. As you explore this list, you’ll also understand how a trusted manufacturer like Medyra Pharma ensures consistent supply, stringent quality control and global reach.

Types of Anti-Cancer Drugs

When building an effective anti cancer drugs list, it helps to categorise by mechanism and use. Below are the major types:

Chemotherapy agents: These kill or damage rapidly dividing cancer cells directly.

Hormonal therapies: Drugs that block or mimic hormones to stop hormone-sensitive cancers (e.g., breast, prostate).

Targeted therapy drugs: Medications that target specific molecules in cancer cells (e.g., kinase inhibitors).

Immunotherapy drugs: Treatments that empower the body’s immune system to recognise and attack cancer.

Alkylating agents & cytotoxic antibiotics: These interfere with DNA or cell division to suppress cancer growth.

Medyra Pharma’s commitment as a manufacturer ensures that each drug class in our oncology portfolio is developed under strict GMP/GLP standards and delivered to over 30 countries worldwide. medyraonco.com

Commonly Used Anti-Cancer Medicines

Here’s a curated anti cancer drugs list frequently used by oncologists — each supported by proven clinical use:

Cisplatin – used in bladder, ovarian, lung cancers.

Carboplatin – similar use; lower toxicity.

Cyclophosphamide – lymphoma, leukemia, breast cancer.

Methotrexate – folate antagonist for various solid tumours.

Paclitaxel (Taxol) – derived from plants; used in ovarian & breast cancer.

Doxorubicin (Adriamycin) – solid tumours, widely utilised.

Tamoxifen – a hormonal therapy used in breast cancer.

Imatinib (Gleevec) – targeted therapy for chronic myeloid leukaemia.

Pembrolizumab (Keytruda) – immunotherapy for melanoma, lung cancer.

Etoposide – testicular, small-cell lung cancer indications.

Each of these shares one important link: the need for reliable manufacturing and global distribution—roles fulfilled by Medyra Pharma as an anti cancer drugs manufacturer with a strong global presence. medyraonco.com

How Anti-Cancer Drugs Work

To understand any effective anti cancer drugs list, it helps to see how the medicines function:

Direct cell kill / DNA damage: Chemotherapy and alkylating agents target dividing cells.

Signal inhibition: Targeted therapies shut down molecular pathways driving cancer.

Hormone blockade: Hormonal agents interfere with cancer growth driven by hormones.

Immune activation: Immunotherapies enable immune-cells to identify and eliminate tumour cells.

At Medyra Pharma, our rigorous manufacturing processes ensure these mechanisms translate into safe, stable, and potent medicines. Our quality focus and global export reach to 30+ countries reinforce our role as a leading anti cancer drugs manufacturer. medyraonco.com

Conclusion

Ibrutinib is the generic name for the drug Imbruvica, an anti-cancer drug.

It is a targeted therapy with the function of inhibiting Bruton's tyrosine kinase (BTK) protein.

The anti-cancer drug is used to treat Chronic lymphocytic leukemia (CLL), Mantle cell lymphoma (MCL), Marginal zone lymphoma (MZL), and Waldenstrom's macroglobulinemia.

Palbocicilib is the generic version of Ibrance.

It is taken to prevent the growth of cancer cells, especially for breast cancers.

Palbocicilib is used as a targeted therapy.

The medicine is used in combination with letrozole to treat locally advanced or secondary breast cancer.That is women suffering from oestrogen receptor positive (ER+) and HER2 negative.

Osimertinib tablet was approved for cancer treatment by Food and Drug Administration and European Union in 2017.

It is a  salt which is  used to treat advanced or metastatic lung cancer.

It works efficiently against cancer cells that have been tested positive for T790M mutation in the EGFR gene.

Leucovorin Calcium Tablets